Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Colorcon
Mallinckrodt
Dow
AstraZeneca

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

BENZACLIN Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Benzaclin patents expire, and what generic alternatives are available?

Benzaclin is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in BENZACLIN is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

Drug patent expirations by year for BENZACLIN
Drug Prices for BENZACLIN

See drug prices for BENZACLIN

Drug Sales Revenue Trends for BENZACLIN

See drug sales revenues for BENZACLIN

Recent Clinical Trials for BENZACLIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Glenmark Pharmaceuticals Ltd. IndiaPhase 3
Taro Pharmaceuticals USAPhase 1
Loreal USAN/A

See all BENZACLIN clinical trials

Pharmacology for BENZACLIN
Synonyms for BENZACLIN
(2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDE HYDROCHLORIDE
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
18323-44-9 (Parent)
21462-39-5
26884-28-6
32795-16-7
462C395
58207-19-5
AB0071584
AB43001
AC-12179
ACT02688
AKOS015843964
AKOS015960823
Antirobe vet.
AS-13649
AT-13884
AUODDLQVRAJAJM-XJQDNNTCSA-N
BIC0117
C13684
CAS-21462-39-5
CHEMBL1200588
Cleocin
Cleocin HCl
Cleocin hydrochloride
Cleocin hydrochloride (TN)
Clindamycin (hydrochloride)
CLINDAMYCIN ALCOHOLATE
Clindamycin Hcl
Clindamycin HCl (Dalacin)
Clindamycin hydrochloride
Clindamycin hydrochloride (Dalacin)
Clindamycin hydrochloride (JP17/USP)
Clindamycin hydrochloride [USP:BAN:JAN]
Clindamycin hydrochloride monohydrate
Clindamycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Clindamycin hydrochloride, lincosamide antibiotic
Clindimycin hydrochloride
Clindoxyl
Clinsol
Clintabs
CS-2508
D02132
Dalacin (TN)
DSSTox_CID_25428
DSSTox_GSID_45428
DSSTox_RID_80872
DTXSID4045428
DUAC
EC 244-398-6
HY-B0408A
J10047
Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride
MFCD07793327
MolPort-003-983-294
MolPort-016-633-350
NCGC00016752-01
s2457
SCHEMBL3153
ST2406750
T20OQ1YN1W
Tox21_110591
U 21251F
U-25179E
UNII-T20OQ1YN1W
Z-4007
ZX-AFC000484

US Patents and Regulatory Information for BENZACLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch BENZACLIN benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 050756-001 Dec 21, 2000 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Bausch BENZACLIN benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 050756-002 Apr 20, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
McKesson
Baxter
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.